FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

725650009: Pramipexole dihydrochloride monohydrate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3444734012 Pramipexole dihydrochloride monohydrate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3444735013 Pramipexole dihydrochloride monohydrate en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pramipexole dihydrochloride monohydrate Is a Pramipexole dihydrochloride false Inferred relationship Existential restriction modifier
Pramipexole dihydrochloride monohydrate Has disposition Dopamine receptor agonist true Inferred relationship Existential restriction modifier
Pramipexole dihydrochloride monohydrate Is a Substance with dopamine receptor agonist mechanism of action true Inferred relationship Existential restriction modifier
Pramipexole dihydrochloride monohydrate Is modification of Pramipexole dihydrochloride true Inferred relationship Existential restriction modifier
Pramipexole dihydrochloride monohydrate Is a Antiparkinsonian agent true Inferred relationship Existential restriction modifier
Pramipexole dihydrochloride monohydrate Is a Drug allergen false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Pramipexole 1.57mg modified-release tablets (Teva UK Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 1.05mg modified-release tablets (Teva UK Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 520microgram modified-release tablets (Teva UK Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 260microgram modified-release tablets (Teva UK Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 3.15mg modified-release tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 2.1mg modified-release tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 1.57mg modified-release tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 1.05mg modified-release tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 520microgram modified-release tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 260microgram modified-release tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets (A A H Pharmaceuticals Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 3.15mg modified-release tablets (A A H Pharmaceuticals Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets (A A H Pharmaceuticals Ltd) 30 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 3.15mg modified-release tablets (A A H Pharmaceuticals Ltd) 30 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 88microgram tablets (Wockhardt UK Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 180microgram tablets (Wockhardt UK Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Wockhardt UK Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 700microgram tablets (Wockhardt UK Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 1.57mg modified-release tablets (A A H Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 2.1mg modified-release tablets (A A H Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 1.05mg modified-release tablets (A A H Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 520microgram modified-release tablets (A A H Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 260microgram modified-release tablets (A A H Pharmaceuticals Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 260microgram modified-release tablets (A A H Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Oprymea 0.26mg modified-release tablets (Krka UK Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Oprymea 1.57mg modified-release tablets (Krka UK Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Oprymea 2.1mg modified-release tablets (Krka UK Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Oprymea 0.52mg modified-release tablets (Krka UK Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Oprymea 1.05mg modified-release tablets (Krka UK Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Oprymea 0.26mg modified-release tablets (Krka UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Oprymea 1.57mg modified-release tablets (Krka UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Oprymea 2.1mg modified-release tablets (Krka UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Oprymea 0.52mg modified-release tablets (Krka UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Oprymea 1.05mg modified-release tablets (Krka UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Accord Healthcare Ltd) 30 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Oprymea 3.15mg modified-release tablets (Krka UK Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Oprymea 2.62mg modified-release tablets (Krka UK Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 88microgram tablets (Aspire Pharma Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 1.05mg modified-release tablets (A A H Pharmaceuticals Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 1.57mg modified-release tablets (A A H Pharmaceuticals Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 2.1mg modified-release tablets (A A H Pharmaceuticals Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 520microgram modified-release tablets (A A H Pharmaceuticals Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 3.15mg modified-release tablets 30 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 2.1mg modified-release tablets 30 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 1.05mg modified-release tablets 30 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 1.05mg modified-release tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.26mg modified-release tablets (Boehringer Ingelheim Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.52mg modified-release tablets (Boehringer Ingelheim Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Boehringer Ingelheim Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 2.1mg modified-release tablets (Boehringer Ingelheim Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 520microgram modified-release tablets 30 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 260microgram modified-release tablets 30 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.7mg tablets (Lexon (UK) Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.18mg tablets (Lexon (UK) Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.7mg tablets (Lexon (UK) Ltd) 30 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.18mg tablets (Lexon (UK) Ltd) 30 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.18mg tablets (Mawdsley-Brooks & Company Ltd) 100 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.7mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.7mg tablets (Mawdsley-Brooks & Company Ltd) 100 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 2.1mg modified-release tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 260microgram modified-release tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 3.15mg modified-release tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 520microgram modified-release tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.18mg tablets (Stephar (U.K.) Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.7mg tablets (Stephar (U.K.) Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.088mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.18mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.26mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.52mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 2.1mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.18mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.7mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.18mg tablets (Stephar (U.K.) Ltd) 30 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.7mg tablets (Stephar (U.K.) Ltd) 30 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.088mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 1.57mg modified-release tablets (Boehringer Ingelheim Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Boehringer Ingelheim Ltd) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.52mg modified-release tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.26mg modified-release tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 2.1mg modified-release tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 3.15mg modified-release tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 1.57mg modified-release tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 520microgram modified-release tablets 10 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 260microgram modified-release tablets 10 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 700microgram tablets (PI) (Mawdsley-Brooks & Company Ltd) (product) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 2.1mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 700microgram tablets (PI) (Mawdsley-Brooks & Company Ltd) 30 tablet (product) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 700microgram tablets (Mawdsley-Brooks & Company Ltd) 100 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 700microgram tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Sigma Pharmaceuticals Plc) 100 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 700microgram tablets (Sigma Pharmaceuticals Plc) 30 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Pramipexole 700microgram tablets (Sigma Pharmaceuticals Plc) 100 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Mirapexin 0.7mg tablets (Stephar (U.K.) Ltd) 100 tablet Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Oprymea 0.35mg tablets (Krka UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Oprymea 0.35mg tablets (Krka UK Ltd) 100 tablet 10 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
Oprymea 0.7mg tablets (Krka UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier

Start Previous Page 3 of 6 Next End

This concept is not in any reference sets

Back to Start